May 30, 2026
Bromantane (brand name Ladasten) occupies a unique position in psychopharmacology. Unlike amphetamines or methylphenidate, it enhances dopamine synthesis rather than blocking reuptake — producing stimulation without jitters, addiction potential, or a crash. Here's what the research tells us.
| Property | Bromantane | Traditional Stimulants |
|---|---|---|
| Mechanism | Upregulates tyrosine hydroxylase (dopamine synthesis) | Blocks DAT/NET (reuptake inhibition) |
| Onset | Gradual (hours to days) | Rapid (minutes) |
| Addiction potential | Minimal (no reinforcement in animal models) | Moderate to high |
| Anxiolytic effect | Yes (unique dual action) | No (often anxiogenic) |
| Crash/withdrawal | None reported | Common |
Bromantane's primary mechanism is upregulation of tyrosine hydroxylase (TH) — the rate-limiting enzyme in dopamine synthesis. It also enhances aromatic L-amino acid decarboxylase (AADC) expression. The net effect: your neurons produce more dopamine rather than just holding existing dopamine in the synapse longer.
Additionally, bromantane has serotonergic effects that contribute to its anxiolytic profile — making it one of the few compounds that is simultaneously stimulating and calming.
Bromantane was developed in Russia for treating asthenia (chronic fatigue) and anxiety. Research applications include:
If you're sourcing bromantane for research, purity is critical. Bromantane (CAS 87913-26-6, molecular formula C16H20BrN, MW 306.25) should be verified by HPLC and mass spectrometry. Request a third-party COA showing both the purity percentage and the full chromatogram.